Stock Track | RadNet Soars 5.08% Intraday as Barclays Reiterates Buy Rating

Stock Track

2025/01/22

RadNet (RDNT) shares surged 5.08% intraday on Wednesday, driven by Barclays' bullish stance on the medical imaging company.

Barclays analyst Andrew Mok CFA maintained a Buy rating on RadNet and set a price target of $74.00. This positive outlook from the analyst appears to be fueling the stock's rally.

RadNet has been viewed favorably by analysts due to its strong growth prospects and leadership position in the outpatient imaging services market. The company is expected to benefit from increasing demand for diagnostic imaging procedures as the population ages.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1146292539"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1146292539\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1146292539?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-22 23:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146292539","market":"hk","top_or_hot":-1,"title":"Stock Track | RadNet Soars 5.08% Intraday as Barclays Reiterates Buy Rating","media":"Stock Track","content":"<p>RadNet (RDNT) shares surged 5.08% intraday on Wednesday, driven by Barclays' bullish stance on the medical imaging company.</p>\n\n<p>Barclays analyst Andrew Mok CFA maintained a Buy rating on RadNet and set a price target of $74.00. This positive outlook from the analyst appears to be fueling the stock's rally.</p>\n\n<p>RadNet has been viewed favorably by analysts due to its strong growth prospects and leadership position in the outpatient imaging services market. The company is expected to benefit from increasing demand for diagnostic imaging procedures as the population ages.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | RadNet Soars 5.08% Intraday as Barclays Reiterates Buy Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | RadNet Soars 5.08% Intraday as Barclays Reiterates Buy Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-01-22 23:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>RadNet (RDNT) shares surged 5.08% intraday on Wednesday, driven by Barclays' bullish stance on the medical imaging company.</p>\n\n<p>Barclays analyst Andrew Mok CFA maintained a Buy rating on RadNet and set a price target of $74.00. This positive outlook from the analyst appears to be fueling the stock's rally.</p>\n\n<p>RadNet has been viewed favorably by analysts due to its strong growth prospects and leadership position in the outpatient imaging services market. The company is expected to benefit from increasing demand for diagnostic imaging procedures as the population ages.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RDNT","symbol_name":"RadNet","start_time":0,"source_url":"","article_id":"1146292539","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146292539","pubTimestamp":1737559701,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"RadNet  shares surged 5.08% intraday on Wednesday, driven by Barclays' bullish stance on the medical imaging company.Barclays analyst Andrew Mok CFA maintained a Buy rating on RadNet and set a price target of $74.00. This positive outlook from the analyst appears to be fueling the stock's rally.RadNet has been viewed favorably by analysts due to its strong growth prospects and leadership position in the outpatient imaging services market. The company is expected to benefit from increasing demand","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RDNT":"RadNet"},"translate_title":"巴克莱重申买入评级，股票跟踪RadNet盘中飙升5.08%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RDNT":1},"content_text":"RadNet (RDNT) shares surged 5.08% intraday on Wednesday, driven by Barclays' bullish stance on the medical imaging company.\nBarclays analyst Andrew Mok CFA maintained a Buy rating on RadNet and set a price target of $74.00. This positive outlook from the analyst appears to be fueling the stock's rally.\nRadNet has been viewed favorably by analysts due to its strong growth prospects and leadership position in the outpatient imaging services market. The company is expected to benefit from increasing demand for diagnostic imaging procedures as the population ages.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}